Stay updated on Ublituximab in RMS: Clinical Trial

Sign up to get notified when there's something new on the Ublituximab in RMS: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ublituximab in RMS: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No substantive changes to the study details were observed between screenshots; core information remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T12:53:40.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Added a government-funding/status notice and upgraded version to v3.2.0; removed the old v3.1.0 tag.
    Difference
    4%
    Check dated 2025-10-05T17:33:01.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    New version tag v3.1.0 added and several MedlinePlus topics removed (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); older version tag v3.0.2 removed. Core page content and topic scope updated accordingly.
    Difference
    0.6%
    Check dated 2025-09-28T10:50:54.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T00:39:12.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.2%
    Check dated 2025-09-06T21:27:48.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information for Ublituximab and Teriflunomide, along with a significant study reference, while removing several related topics and terms, particularly those associated with Teriflunomide.
    Difference
    7%
    Check dated 2025-08-30T16:03:19.000Z thumbnail image

Stay in the know with updates to Ublituximab in RMS: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ublituximab in RMS: Clinical Trial page.